Australian Institute of Health and Welfare 2021. Alcohol and other drug treatment services in Australia annual report. Cat. no. HSE 250. Canberra: AIHW. Viewed 24 July 2021, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. (2021). Alcohol and other drug treatment services in Australia annual report. Retrieved from https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Alcohol and other drug treatment services in Australia annual report. Australian Institute of Health and Welfare, 16 July 2021, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia annual report [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2021 Jul. 24]. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare (AIHW) 2021, Alcohol and other drug treatment services in Australia annual report, viewed 24 July 2021, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Get citations as an Endnote file:
PDF | 9.8Mb
On this page:
In 2019–20, 338 publicly funded alcohol and other drug treatment agencies in Victoria provided 86,142 closed treatment episodes to 37,391 clients (tables SA.1, SCR.21).
a 33% increase in closed treatment episodes from 64,546 in 2018–19 to 86,142 in 2019–20 due to the ability of the new collection system to capture service types not able to be reported previously (such as support); and a 34% increase in closed treatment episodes compared with 2015–16 (64,118).
an 11% increase in clients between 2018–19 to 2019–20 (37,391), due to system changes and flexible AOD treatment delivery with improved reporting (note: 2015–16 client numbers are based on imputed values). Clients numbers remained consistent from 2015–16 (33,312) to 2018–19 (33,699).
The visualisation shows that 86,142 closed treatment episodes were provided to an estimated 37,391 clients in Victoria in 2019–20. This equates to a rate of 1,477 episodes and 641 clients per 100,000 population, compared with 1,064 episodes and 624 clients per 100,000 population reported nationally.
In 2019–20, nearly 7 in 10 (69%) clients in Victoria attended 1 agency and received an average of 2.3 closed treatment episodes, which is higher than the national average of 1.7 treatment episodes (tables SCR.21, SCR.23). This is due to the nuances of Victoria’s data collection system, where each type of treatment results in a separate treatment episode.
The visualisation includes a series of horizontal bar graphs showing that, in 2019–20, 4 in 5 (82%) clients in Victoria received treatment for their own drug use. Of these clients, just under two-thirds (65%) were male, 58% were aged 20–39, and 8% were Indigenous Australians. Nearly all clients (95%) listed English as their preferred language and most (85%) were born in Australia.
Over the period 2015–16 to 2019–20, 111,525 clients received treatment in Victoria. Of these clients:
In 2019–20, for clients in Victoria receiving treatment episodes for their own alcohol or drug use:
Victoria is working with service providers to encourage more specific reporting of amphetamine use (i.e. to reduce the use of ‘amphetamines not further defined’ code where possible).
Victoria reported comparatively high incidences of ‘Not stated drugs’ (15%) as the drug of concern. This is in part due to service providers adjusting to changes in reporting practices associated with the implementation of a new data collection system in 2019–20. Victoria is working with service providers to encourage more specific reporting of drug of concern.
Clients can nominate up to 5 additional drugs of concern; these drugs are not necessarily the subject of any treatment within the episode (see Technical notes).
In 2019–20, when the client reported additional drugs of concern:
Over the period 2015–16 to 2019–20:
The grouped horizontal bar chart shows that, in 2019–20, the most common principal drug of concern in treatment episodes provided to clients in Victoria for their own drug use was amphetamines (29%). This was followed by alcohol (28%), cannabis (16%), and heroin (5.3%). Cannabis was the most common additional drug of concern (10%), followed by nicotine (9.6%), alcohol (8.1%), and amphetamines (5.5%).
The line graph shows that, from 2015–16 to 2019–20, amphetamines not further defined was the most common drug of concern among meth/amphetamine-related treatment episodes for clients’ own use until 2019–20 when methamphetamine became the most common drug of concern (60%). The proportion of episodes for amphetamines not further defined decreased from 2017–18 (91% of meth/amphetamine-related episodes) to 2019–20 (36%), while it increased for methamphetamines (from 5.9% to 60%).
The stacked horizontal bar chart shows the method of use for treatment episodes related to clients’ own use of methamphetamine, amphetamine, amphetamines not further defined, and other amphetamines in Victoria in 2019–20. Smoking was the most common method of use across all amphetamine codes (56–64% of treatment episodes), followed by injecting (17–24% of episodes).
In 2019–20, for treatment episodes in Victoria:
In 2019–20, Victoria finalised implementation of a new data collection system (VADC) which allows agencies to report additional treatment types against the AODTS NMDS. As a result, there will be differences in the proportion of additional treatment types reported prior to 2019–20.
Where an additional treatment was provided as a supplementary to the main treatment, ‘other’ treatment (2%) was the most common (Table SE VIC.20). See technical notes for further information on calculating proportions for additional treatment type.
Over the period from 2015–16 to 2019–20:
The grouped horizontal bar chart shows that, in 2019–20, the most common main treatment type provided to clients in Victoria for their own drug use was support and case management (28% of episodes). This was followed by counselling (27%), assessment only (25%), and withdrawal management (8.6%). Additional treatment types were uncommon, reported in less than 1% of treatment episodes.
In 2019–20 in Victoria:
In the period from 2015–16 to 2019–20:
Victoria reported an increase in the number of in-scope services in 2019–20 due to improved data collection systems which allow reporting at the service outlet location rather than head office level (see the Data Quality Statement).
The horizontal bar chart shows that Victoria does not have any areas classified as Remote or Very remote. Most treatment agencies in Victoria were located in Major cities (208 agencies), followed by Inner regional (98 agencies) and Outer regional (32 agencies) areas. Nearly all (335 agencies) of the total 338 agencies were non-government.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.